Clinical Trial

Silent Threat: Impact of Preoperative Albumin Levels on Outcomes in Geriatric Cancer Surgery

Completed
View on ClinicalTrials.gov →
Summary
This retrospective, single-center study aims to evaluate the impact of preoperative albumin levels on postoperative outcomes in geriatric patients (aged 65 and above) undergoing cancer surgery. The study will compare postoperative complication rates, length of hospital stay, and intensive care needs between patients with hypoalbuminemia and those with normal albumin levels.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-28; most recent amendment 2026-04-26.
Trial Details
NCT Number NCT06998030
Lead Sponsor Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Conditions Neoplasms, Aged, Hypoalbuminemia, Postoperative Complications, Malnutrition
Enrollment 330 participants
Start Date 2025-04-01
Primary Completion 2025-04-30 (estimated)
Study Completion 2025-05-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-30